A possible involvement of endocannabinoids in a chronic model of endotoxemia was assessed by measuring the regional (renal, mesenteric, hindquarters) hemodynamic responses to continuous 24-h LPS infusion (150 g ⅐ kg Ϫ1 ⅐ h Ϫ1 ) in conscious, male Sprague-Dawley rats, in the absence or presence of the cannabinoid (CB 1) receptor antagonist AM-251 (3 mg/kg). AM-251 inhibited the tachycardic and hindquarters vasodilator effects of LPS, but did not influence the other hemodynamic changes. In subsequent experiments, it was shown that the tachycardic and hindquarters vasodilator effects of LPS were also inhibited by the nonselective -adrenoceptor antagonist propranolol. In addition, the late (at 24 h) hindquarters vasodilator effects of LPS were inhibited by the 2-adrenoceptor antagonist ICI-118551. Against the background of our previous work showing -adrenoceptor involvement in the cardiovascular effects of exogenous cannabinoids, we conclude that AM-251 may have been inhibiting endocannabinoid-modulated, sympathoadrenal-mediated activation of vasodilator -adrenoceptors in LPS-infused rats rather than suppressing a direct vasodilator action of endocannabinoids.AM-251; endotoxemia; vasodilatation THE SYSTEMIC RESPONSE TO BACTERIAL infection, often referred to as sepsis, involves complex pathogenetic mechanisms and associated cardiovascular changes (26). Before the development of septic shock, there may be a hyperdynamic phase of sepsis with high cardiac output and peripheral vasodilatation (26). The underlying causes of the vasodilatation are multifactorial, involving the loss of vascular sensitivity to vasoconstrictors (25), some of which may be released through nonbaroreflex-mediated processes (39) and possibly contributed to by disorders of baroreflex control (29). In addition, there are numerous potential vasodilator mediators reported to be involved in the cardiovascular sequelae of sepsis (25).Endotoxemia induced by the administration of the bacterial cell wall product, LPS, to experimental animals is often used to model some of the pathophysiological changes occurring in sepsis. In a model of endotoxemia, involving a large bolus dose of LPS in anesthetized male Sprague-Dawley rats, Varga et al. -141716A) prevented the fall in mean arterial blood pressure. In addition, LPS stimulated the production of endocannabinoids by platelets and macrophages, although increased circulating levels of these substances were not directly demonstrated in LPS-treated rats (33). The same group has also shown an involvement of endogenous cannabinoids in the hypotension associated with hemorrhagic shock (35) and after myocardial infarction (34). In vitro studies (28) have shown cannabinoids cause vasodilatation by a variety of mechanisms, including release of endothelium-derived hyperpolarizing factor, activation of potassium channels, inhibition of calcium channels, direct effects of cannabinoid receptors on vascular smooth muscle, release of mediators from sensory nerves, and presynaptic inhibition of norepinephrine release. ...